• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用连续容积筛查 12 个月检测肺结节中的癌症概率:英国纵向研究。

Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial.

机构信息

Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK

Barts and London, Wolfson Institute of Preventive Medicine, London, UK.

出版信息

Thorax. 2019 Aug;74(8):761-767. doi: 10.1136/thoraxjnl-2018-212263. Epub 2019 Apr 26.

DOI:10.1136/thoraxjnl-2018-212263
PMID:31028232
Abstract

BACKGROUND

Estimation of the clinical probability of malignancy in patients with pulmonary nodules will facilitate early diagnosis, determine optimum patient management strategies and reduce overall costs.

METHODS

Data from the UK Lung Cancer Screening trial were analysed. Multivariable logistic regression models were used to identify independent predictors and to develop a parsimonious model to estimate the probability of lung cancer in lung nodules detected at baseline and at 3-month and 12-month repeat screening.

RESULTS

Of 1994 participants who underwent CT scan, 1013 participants had a total of 5063 lung nodules and 52 (2.6%) of the participants developed lung cancer during a median follow-up of 4 years. Covariates that predict lung cancer in our model included female gender, asthma, bronchitis, asbestos exposure, history of cancer, early and late onset of family history of lung cancer, smoking duration, FVC, nodule type (pure ground-glass and part-solid) and volume as measured by semiautomated volumetry. The final model incorporating all predictors had excellent discrimination: area under the receiver operating characteristic curve (AUC 0.885, 95% CI 0.880 to 0.889). Internal validation suggested that the model will discriminate well when applied to new data (optimism-corrected AUC 0.882, 95% CI 0.848 to 0.907). The risk model had a good calibration (goodness-of-fit χ[8] 8.13, p=0.42).

CONCLUSIONS

Our model may be used in estimating the probability of lung cancer in nodules detected at baseline and at 3 months and 12 months from baseline, allowing more efficient stratification of follow-up in population-based lung cancer screening programmes.

TRIAL REGISTRATION NUMBER

摘要

背景

在肺结节患者中评估临床恶性肿瘤概率有助于早期诊断,确定最佳患者管理策略并降低总体成本。

方法

对英国肺癌筛查试验的数据进行了分析。使用多变量逻辑回归模型来识别独立预测因子,并开发一个简约模型来估算基线时以及 3 个月和 12 个月重复筛查时检测到的肺结节中肺癌的概率。

结果

在接受 CT 扫描的 1994 名参与者中,有 1013 名参与者总共出现 5063 个肺结节,其中 52 名(2.6%)参与者在中位数为 4 年的随访期间发生了肺癌。在我们的模型中,预测肺癌的协变量包括女性性别、哮喘、支气管炎、石棉暴露、癌症史、肺癌家族史的早发和晚发、吸烟持续时间、FVC、结节类型(纯磨玻璃和部分实性)以及半自动体积测量法测量的体积。纳入所有预测因子的最终模型具有出色的判别能力:接受者操作特征曲线下面积(AUC 0.885,95%CI 0.880 至 0.889)。内部验证表明,当应用于新数据时,该模型将具有良好的判别能力(校正后的 AUC 0.882,95%CI 0.848 至 0.907)。该风险模型具有良好的校准度(拟合优度 χ[8] 8.13,p=0.42)。

结论

我们的模型可用于估算基线时以及 3 个月和 12 个月时检测到的结节中肺癌的概率,从而在基于人群的肺癌筛查计划中更有效地对随访进行分层。

试验注册号

78513845。

相似文献

1
Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial.使用连续容积筛查 12 个月检测肺结节中的癌症概率:英国纵向研究。
Thorax. 2019 Aug;74(8):761-767. doi: 10.1136/thoraxjnl-2018-212263. Epub 2019 Apr 26.
2
Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.基于低剂量 CT 检测肺结节的良恶性鉴别预测模型评估。
JAMA Netw Open. 2020 Feb 5;3(2):e1921221. doi: 10.1001/jamanetworkopen.2019.21221.
3
Predicting Malignancy Risk of Screen-Detected Lung Nodules-Mean Diameter or Volume.基于直径或体积预测筛查性肺结节的恶性风险
J Thorac Oncol. 2019 Feb;14(2):203-211. doi: 10.1016/j.jtho.2018.10.006. Epub 2018 Oct 25.
4
Probability of cancer in pulmonary nodules detected on first screening CT.首次筛查 CT 检测到的肺结节的癌症概率。
N Engl J Med. 2013 Sep 5;369(10):910-9. doi: 10.1056/NEJMoa1214726.
5
Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.低剂量 CT 肺癌筛查中新出现实性结节的发生率和肺癌概率:来自随机、对照 NELSON 试验的数据分析。
Lancet Oncol. 2016 Jul;17(7):907-916. doi: 10.1016/S1470-2045(16)30069-9. Epub 2016 Jun 6.
6
Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.低剂量 CT 肺癌筛查中检出的新发实性结节的特征:NELSON 研究。
Thorax. 2018 Aug;73(8):741-747. doi: 10.1136/thoraxjnl-2017-211376. Epub 2018 Apr 16.
7
External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data.利用 NLST 数据对 Brock 模型进行外部验证和重新校准,以预测肺结节中癌症的概率。
Thorax. 2019 Jun;74(6):551-563. doi: 10.1136/thoraxjnl-2018-212413. Epub 2019 Mar 21.
8
Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.CT 检测到肺结节患者的肺癌概率:来自低剂量 CT 筛查 NELSON 试验数据的预设分析。
Lancet Oncol. 2014 Nov;15(12):1332-41. doi: 10.1016/S1470-2045(14)70389-4. Epub 2014 Oct 1.
9
Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.肺癌筛查中基于放射组学列线图的恶性肺结节术前诊断。
Cancer Commun (Lond). 2020 Jan;40(1):16-24. doi: 10.1002/cac2.12002. Epub 2020 Mar 3.
10
Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines.基于基线 CT 筛查结节的恶性风险评估:PanCan 模型、Lung-RADS 和 NCCN 指南的比较。
Eur Radiol. 2017 Oct;27(10):4019-4029. doi: 10.1007/s00330-017-4767-2. Epub 2017 Mar 14.

引用本文的文献

1
Performance of volume and diameter thresholds in malignancy prediction of solid nodules in lung cancer screening.肺癌筛查中实性结节恶性预测的体积和直径阈值性能
Thorax. 2025 Aug 15;80(9):624-631. doi: 10.1136/thorax-2024-222086.
2
Network pharmacology and molecular docking analysis on the mechanism of Wensan tincture in the treatment of pulmonary nodules: A review.网络药理学和分子对接分析温三酊治疗肺结节的作用机制:综述。
Medicine (Baltimore). 2024 Nov 29;103(48):e40648. doi: 10.1097/MD.0000000000040648.
3
Biomarkers in Cancer Screening: Promises and Challenges in Cancer Early Detection.
癌症筛查中的生物标志物:癌症早期检测的前景与挑战。
Hematol Oncol Clin North Am. 2024 Aug;38(4):869-888. doi: 10.1016/j.hoc.2024.04.004. Epub 2024 May 22.
4
Expanding Role of Advanced Image Analysis in CT-detected Indeterminate Pulmonary Nodules and Early Lung Cancer Characterization.高级图像分析在 CT 检测到的肺部不确定结节和早期肺癌特征中的作用不断扩大。
Radiology. 2023 Oct;309(1):e222904. doi: 10.1148/radiol.222904.
5
Circulating proteome for pulmonary nodule malignancy.循环蛋白质组学在肺结节良恶性诊断中的应用
J Natl Cancer Inst. 2023 Sep 7;115(9):1060-1070. doi: 10.1093/jnci/djad122.
6
A strategy to reduce the false-positive rate after low-dose computed tomography in lung cancer screening: A multicenter prospective cohort study.降低肺癌筛查中低剂量 CT 假阳性率的策略:一项多中心前瞻性队列研究。
Cancer Med. 2023 Jul;12(13):14781-14793. doi: 10.1002/cam4.6106. Epub 2023 May 18.
7
Value of IVIM in Differential Diagnoses between Benign and Malignant Solitary Lung Nodules and Masses: A Meta-analysis.体素内不相干运动成像在孤立性肺良恶性结节及肿块鉴别诊断中的价值:一项Meta分析
Front Surg. 2022 Jun 1;9:817443. doi: 10.3389/fsurg.2022.817443. eCollection 2022.
8
Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.低剂量计算机断层扫描(LDCT)筛查对肺癌相关死亡率的影响。
Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD013829. doi: 10.1002/14651858.CD013829.pub2.
9
Development, Validation, and Comparison of Image-Based, Clinical Feature-Based and Fusion Artificial Intelligence Diagnostic Models in Differentiating Benign and Malignant Pulmonary Ground-Glass Nodules.基于图像、临床特征和融合人工智能诊断模型在鉴别肺磨玻璃结节良恶性中的开发、验证及比较
Front Oncol. 2022 Jun 7;12:892890. doi: 10.3389/fonc.2022.892890. eCollection 2022.
10
Comprehensive Analysis of Clinical Logistic and Machine Learning-Based Models for the Evaluation of Pulmonary Nodules.基于临床逻辑和机器学习的肺结节评估模型的综合分析
JTO Clin Res Rep. 2022 Feb 22;3(4):100299. doi: 10.1016/j.jtocrr.2022.100299. eCollection 2022 Apr.